Dr. Jeffrey Chamberlain is the principal investigator of the Chamberlain Lab
in the Department of Neurology, University of Washington School of Medicine and director
of the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. The main
focus of our research is on the muscular dystrophies, primarily Duchenne muscular dystrophy
(DMD), with two major goals: to develop a better understanding of the molecular basis of
the pathophysiology of the diseases, and to develop gene and cell therapies that will correct
and treat the muscular dystrophies. DMD is the most common form of muscular dystrophy,
affecting one in 3,500 newborn males, and is caused by mutations in the dystrophin
Currently, the laboratory includes ~20 scientists conducting cutting
edge studies that we hope to translate into clinical trials in the near future.
We are working with some of the best doctors and scientists at Children's Hospital,
Fred Hutchinson Cancer Research Center, the VA Hospital, and Harborview Medical
Center to most effectively tackle the challenge ahead: to find a treatment for
Dr. Chamberlain's book Duchenne Muscular Dystrophy: Advances in Therapeutics (Neurological Disease
and Therapy) can be purchased at Amazon.com.
The Harmonize for Hope organization offers blue "HOPE" bracelets to support the Chamberlain Lab and muscular dystrophy research:
To purchase bracelets and learn more, visit the Harmonize for Hope website.